Novocure (NVCR) Tops Q3 EPS by 9c

Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $167 million versus the consensus estimate of $158.54 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.

You May Also Be Interested In

• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• Lazard AUM rises to $290.3 billion at end of August 2026
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue